Migraine and Obesity: Moving Beyond Bmi

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

A Recober has received funding from NIH/NINDS (grant K08-NS066087) and a consulting fee from Allergan (unrelated to current manuscript). BL Peterlin has received funding from NIH/NINDS (grant K23-NS078345) and a Landenberger Foundation grant for a study unrelated to the current manuscript, and serves as an associate editor for the journals Headache and BMC Neurology. BL Peterlin also receives investigator-initiated research support from GlaxoSmithKline and Luitpold Pharmaceuticals for studies unrelated to the current manuscript, and royalties from Oxford University Press. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

A Recober has received funding from NIH/NINDS (grant K08-NS066087) and a consulting fee from Allergan (unrelated to current manuscript). BL Peterlin has received funding from NIH/NINDS (grant K23-NS078345) and a Landenberger Foundation grant for a study unrelated to the current manuscript, and serves as an associate editor for the journals Headache and BMC Neurology. BL Peterlin also receives investigator-initiated research support from GlaxoSmithKline and Luitpold Pharmaceuticals for studies unrelated to the current manuscript, and royalties from Oxford University Press. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.